REGISTERED PATENT AGENT

Kellie Fredericks is a patent agent in the chemical practice group of Heslin Rothenberg Farley & Mesiti P.C. Ms. Fredericks has a B.A. in Biology from the University of Rochester and earned her MBA from the State University of New York at Albany. Prior to joining the firm, Ms. Fredericks was a Licensing Associate at Rensselaer Polytechnic Institute’s Office of Technology Commercialization. She also has more than twelve years of experience in start-up pharmaceutical and biotechnology companies, with skills ranging from conducting bench science to directing FDA and USDA clinical trials. Ms. Fredericks is registered to practice as a patent agent before the U.S. Patent and Trademark Office.

Memberships and Organizations:
Tech Valley Licensing Executives Society Steering Committee member 2010-2011
Eastern New York Intellectual Property Law Association Board member 2009-2011
Center for Economic Growth
American Intellectual Property Law Association
Pre-Seed Workshop advisor

Publications:

a.   Kellie S. Fredericks and Shahrokh Falati, Licensing Creations of the Human Mind, The Daily Record, May 18, 2010

b.   S.W. Mamber, V. Long, R.G. Rhodes, S. Pond-Tor, L.R. Wheeler, K. Fredericks, B. VanScoy, J.F. Sauniere, R. Steinschneider, J.C. Laurent, J. McMichael, Nerve growth factor (NGF) has novel antidepressant-like properties in rats; Pharmacology, Biochemistry and Behavior 94: 553-560, 2010

c.   D.H. Overstreet, K. Fredericks, D. Knapp, G. Breese, J. McMichael, THE USE OF STREPTOLYSIN O FOR THE TREATMENT OF SCARS, ADHESIONS AND FIBROSIS: Initial Investigations Using Murine Models of Scleroderma; Nonlinearity in Biology, Toxicology, and Medicine 2: 67–87, 2004